Rhythm Pharmaceuticals Gross Margin Growth & History (RYTM)

Rhythm Pharmaceuticals's gross margin was 89.73% for fiscal 2025.

View full Rhythm Pharmaceuticals company overview

Rhythm Pharmaceuticals annual gross margin history

Rhythm Pharmaceuticals annual gross margin

Fiscal yearPeriod endedGross marginChange (percentage points)
20252025-12-3189.73%+0.00 pp
20242024-12-3189.73%+1.74 pp
20232023-12-3187.99%−2.99 pp
20222022-12-3190.98%+9.97 pp
20212021-12-3181.01%

Rhythm Pharmaceuticals gross margin trends

Between the periods ended 2021-12-31 and 2025-12-31, Rhythm Pharmaceuticals's gross margin increased from 81.01% to 89.73%, a change of +8.72 percentage points. The latest reported quarter, Q2 2026, shows 87.47%.

About the metric

What gross margin means

Gross margin measures the percentage of revenue remaining after the direct costs of producing goods or services. It helps show how efficiently a company turns sales into gross profit before operating expenses.

Calculation and source

How gross margin is calculated

TickerStat calculates gross margin as SEC-reported gross profit divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review Rhythm Pharmaceuticals source filings ↗

Community posts

It’s quiet here.

No posts about RYTM yet. Start the conversation.

Write the first post